Published in Cancers (Basel) on December 04, 2013
Role of Long Noncoding RNA HOTAIR in the Growth and Apoptosis of Osteosarcoma Cell MG-63. Biomed Res Int (2016) 0.77
A novel lncRNA, GASL1, inhibits cell proliferation and restricts E2F1 activity. Oncotarget (2017) 0.75
Effects of LncRNA-HOST2 on cell proliferation, migration, invasion and apoptosis of human hepatocellular carcinoma cell line SMMC-7721. Biosci Rep (2017) 0.75
Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer (2006) 46.47
Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet (2008) 32.08
p53, the cellular gatekeeper for growth and division. Cell (1997) 31.04
The retinoblastoma protein and cell cycle control. Cell (1995) 20.21
Long non-coding RNAs: insights into functions. Nat Rev Genet (2009) 19.61
A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature (2010) 13.82
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (1993) 13.68
Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev (1995) 13.66
Principles of CDK regulation. Nature (1995) 13.09
A cell cycle regulator potentially involved in genesis of many tumor types. Science (1994) 13.00
Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell (1997) 12.41
A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell (2010) 12.27
Non-coding RNAs in human disease. Nat Rev Genet (2011) 11.40
Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell (2009) 11.10
Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol (2008) 11.05
Divergent transcription from active promoters. Science (2008) 11.03
A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell (2011) 10.50
Kcnq1ot1 antisense noncoding RNA mediates lineage-specific transcriptional silencing through chromatin-level regulation. Mol Cell (2008) 9.76
The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res (2007) 9.32
A strategy for probing the function of noncoding RNAs finds a repressor of NFAT. Science (2005) 9.25
Long noncoding RNAs: functional surprises from the RNA world. Genes Dev (2009) 9.14
The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol Cell (2010) 8.66
Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome. Cell (2004) 8.48
Requirement for Xist in X chromosome inactivation. Nature (1996) 8.24
The RB and p53 pathways in cancer. Cancer Cell (2002) 8.02
MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene (2003) 7.90
Genome-wide association study identifies five new breast cancer susceptibility loci. Nat Genet (2010) 7.62
Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet (2009) 7.62
Long noncoding RNAs and human disease. Trends Cell Biol (2011) 7.59
The promises and pitfalls of RNA-interference-based therapeutics. Nature (2009) 7.53
Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription. Nature (2008) 7.18
Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell (2010) 6.94
The p53 pathway. J Pathol (1999) 6.79
Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression. Mol Cell Biol (2007) 6.43
The functional role of long non-coding RNA in human carcinomas. Mol Cancer (2011) 6.37
A screen for nuclear transcripts identifies two linked noncoding RNAs associated with SC35 splicing domains. BMC Genomics (2007) 6.28
Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all. Nat Rev Mol Cell Biol (2006) 6.06
RNA meets chromatin. Genes Dev (2005) 5.66
Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters. Nat Genet (2011) 5.62
Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. Cancer Cell (2007) 5.40
Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells. Nat Genet (2010) 5.37
Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer (2011) 5.12
Rapid evolution of noncoding RNAs: lack of conservation does not mean lack of function. Trends Genet (2005) 5.07
The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res (2012) 5.04
Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene. Oncogene (2010) 4.81
CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res (2010) 4.68
Polycomb group proteins: navigators of lineage pathways led astray in cancer. Nat Rev Cancer (2009) 4.40
DNA damage-inducible transcripts in mammalian cells. Proc Natl Acad Sci U S A (1988) 4.30
Lessons from X-chromosome inactivation: long ncRNA as guides and tethers to the epigenome. Genes Dev (2009) 4.20
New common variants affecting susceptibility to basal cell carcinoma. Nat Genet (2009) 4.15
Overexpression of long non-coding RNA HOTAIR predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation. Ann Surg Oncol (2011) 3.88
LincRNA-p21 suppresses target mRNA translation. Mol Cell (2012) 3.87
The H19 non-coding RNA is essential for human tumor growth. PLoS One (2007) 3.75
eRNAs are required for p53-dependent enhancer activity and gene transcription. Mol Cell (2012) 3.63
Elongation of the Kcnq1ot1 transcript is required for genomic imprinting of neighboring genes. Genes Dev (2006) 3.30
Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med Oncol (2011) 3.24
miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes. Nucleic Acids Res (2008) 3.19
p16(INK4a) translation suppressed by miR-24. PLoS One (2008) 3.08
Activation of p53 by MEG3 non-coding RNA. J Biol Chem (2007) 3.07
Tumour-suppressor activity of H19 RNA. Nature (1993) 3.06
Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest. FEBS Lett (2008) 2.85
ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS. FASEB J (2010) 2.73
The H19 lincRNA is a developmental reservoir of miR-675 that suppresses growth and Igf1r. Nat Cell Biol (2012) 2.73
A pituitary-derived MEG3 isoform functions as a growth suppressor in tumor cells. J Clin Endocrinol Metab (2003) 2.68
A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci. Nat Genet (2010) 2.62
Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B-MYB. PLoS Genet (2013) 2.59
Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer. Carcinogenesis (2009) 2.45
The lncRNA Malat1 is dispensable for mouse development but its transcription plays a cis-regulatory role in the adult. Cell Rep (2012) 2.45
LncRNA loc285194 is a p53-regulated tumor suppressor. Nucleic Acids Res (2013) 2.38
Up-regulated long non-coding RNA H19 contributes to proliferation of gastric cancer cells. FEBS J (2012) 2.26
Elevation of highly up-regulated in liver cancer (HULC) by hepatitis B virus X protein promotes hepatoma cell proliferation via down-regulating p18. J Biol Chem (2012) 2.16
Parental genomic imprinting of the human IGF2 gene. Nat Genet (1993) 2.14
H19 mRNA-like noncoding RNA promotes breast cancer cell proliferation through positive control by E2F1. J Biol Chem (2005) 2.04
Centromere RNA is a key component for the assembly of nucleoproteins at the nucleolus and centromere. Genome Res (2007) 2.03
The H19 locus acts in vivo as a tumor suppressor. Proc Natl Acad Sci U S A (2008) 1.98
Monoallelic expression of the human H19 gene. Nat Genet (1992) 1.96
Distinct regulatory mechanisms and functions for p53-activated and p53-repressed DNA damage response genes in embryonic stem cells. Mol Cell (2012) 1.94
Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma. Proc Natl Acad Sci U S A (2012) 1.91
Malat1 is not an essential component of nuclear speckles in mice. RNA (2012) 1.90
Identification of an imprinted gene, Meg3/Gtl2 and its human homologue MEG3, first mapped on mouse distal chromosome 12 and human chromosome 14q. Genes Cells (2000) 1.90
RB regulates the stability and the apoptotic function of p53 via MDM2. Mol Cell (1999) 1.85
Targeting long non-coding RNA to therapeutically upregulate gene expression. Nat Rev Drug Discov (2013) 1.82
Recurrent focal copy-number changes and loss of heterozygosity implicate two noncoding RNAs and one tumor suppressor gene at chromosome 3q13.31 in osteosarcoma. Cancer Res (2010) 1.81
Maternally expressed gene 3 (MEG3) noncoding ribonucleic acid: isoform structure, expression, and functions. Endocrinology (2009) 1.78
A nucleolar protein, H19 opposite tumor suppressor (HOTS), is a tumor growth inhibitor encoded by a human imprinted H19 antisense transcript. Proc Natl Acad Sci U S A (2011) 1.77
Regulation of cyclin dependent kinase 6 by microRNA 124 in medulloblastoma. J Neurooncol (2008) 1.72
Systematic transcriptome wide analysis of lncRNA-miRNA interactions. PLoS One (2013) 1.68
The human long non-coding RNA-RoR is a p53 repressor in response to DNA damage. Cell Res (2012) 1.66
The haploinsufficient tumor suppressor p18 upregulates p53 via interactions with ATM/ATR. Cell (2005) 1.64
MicroRNA therapeutics. Gene Ther (2011) 1.61
At least ten genes define the imprinted Dlk1-Dio3 cluster on mouse chromosome 12qF1. PLoS One (2009) 1.60
Tumor development in the Beckwith-Wiedemann syndrome is associated with a variety of constitutional molecular 11p15 alterations including imprinting defects of KCNQ1OT1. Hum Mol Genet (2001) 1.58
A 'higher order' of telomere regulation: telomere heterochromatin and telomeric RNAs. EMBO J (2009) 1.56
Controlling the specificity of modularly assembled small molecules for RNA via ligand module spacing: targeting the RNAs that cause myotonic muscular dystrophy. J Am Chem Soc (2009) 1.54
miR-129 regulates cell proliferation by downregulating Cdk6 expression. Cell Cycle (2010) 1.51
Long non-coding RNA ANRIL (CDKN2B-AS) is induced by the ATM-E2F1 signaling pathway. Cell Signal (2013) 1.50
A novel H19 antisense RNA overexpressed in breast cancer contributes to paternal IGF2 expression. Mol Cell Biol (2008) 1.50
Alu elements in ANRIL non-coding RNA at chromosome 9p21 modulate atherogenic cell functions through trans-regulation of gene networks. PLoS Genet (2013) 1.48
Enhanced Mdm2 activity inhibits pRB function via ubiquitin-dependent degradation. EMBO J (2004) 1.47
Phosphorylation of HuR by Chk2 regulates SIRT1 expression. Mol Cell (2007) 5.29
Identification of a target RNA motif for RNA-binding protein HuR. Proc Natl Acad Sci U S A (2004) 5.15
Desperately seeking microRNA targets. Nat Struct Mol Biol (2010) 3.85
miR-200 enhances mouse breast cancer cell colonization to form distant metastases. PLoS One (2009) 2.97
MicroRNAs and their target gene networks in breast cancer. Breast Cancer Res (2010) 2.83
RNA binding activity of the recessive parkinsonism protein DJ-1 supports involvement in multiple cellular pathways. Proc Natl Acad Sci U S A (2008) 2.76
Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B-MYB. PLoS Genet (2013) 2.59
Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function. J Clin Invest (2013) 2.50
HuR: post-transcriptional paths to malignancy. RNA Biol (2005) 2.38
Posttranscriptional orchestration of an anti-apoptotic program by HuR. Cell Cycle (2007) 2.25
Analysis of turnover and translation regulatory RNA-binding protein expression through binding to cognate mRNAs. Mol Cell Biol (2007) 2.24
RNA-binding proteins HuR and PTB promote the translation of hypoxia-inducible factor 1alpha. Mol Cell Biol (2007) 2.20
Nuclear HuR accumulation through phosphorylation by Cdk1. Genes Dev (2008) 2.14
Translational control of cytochrome c by RNA-binding proteins TIA-1 and HuR. Mol Cell Biol (2006) 2.05
Durable protection from Herpes Simplex Virus-2 transmission following intravaginal application of siRNAs targeting both a viral and host gene. Cell Host Microbe (2009) 1.90
Translational repression by RNA-binding protein TIAR. Mol Cell Biol (2006) 1.87
Molecular basis for antagonism between PDGF and the TGFbeta family of signalling pathways by control of miR-24 expression. EMBO J (2009) 1.87
Conserved regulation of p53 network dosage by microRNA-125b occurs through evolving miRNA-target gene pairs. PLoS Genet (2011) 1.55
Ubiquitin-mediated proteolysis of HuR by heat shock. EMBO J (2009) 1.52
Evidence for miR-181 involvement in neuroinflammatory responses of astrocytes. Glia (2013) 1.37
Prostaglandin A2-mediated stabilization of p21 mRNA through an ERK-dependent pathway requiring the RNA-binding protein HuR. J Biol Chem (2004) 1.35
Identification of a signature motif in target mRNAs of RNA-binding protein AUF1. Nucleic Acids Res (2008) 1.25
Bone morphogenetic protein 4 promotes vascular smooth muscle contractility by activating microRNA-21 (miR-21), which down-regulates expression of family of dedicator of cytokinesis (DOCK) proteins. J Biol Chem (2011) 1.10
A p21-ZEB1 complex inhibits epithelial-mesenchymal transition through the microRNA 183-96-182 cluster. Mol Cell Biol (2013) 1.10
Growth inhibition by miR-519 via multiple p21-inducing pathways. Mol Cell Biol (2012) 0.95
Replication stress induces specific enrichment of RECQ1 at common fragile sites FRA3B and FRA16D. Mol Cancer (2013) 0.94
Identification of RECQ1-regulated transcriptome uncovers a role of RECQ1 in regulation of cancer cell migration and invasion. Cell Cycle (2014) 0.92
Modulation of AP and DV signaling pathways by the homeotic gene Ultrabithorax during haltere development in Drosophila. Dev Biol (2006) 0.90
Differential stability of thymidylate synthase 3'-untranslated region polymorphic variants regulated by AUF1. J Biol Chem (2006) 0.88
p53 loss increases the osteogenic differentiation of bone marrow stromal cells. Stem Cells (2015) 0.83
Rosiglitazone inhibits proliferation, motility, and matrix metalloproteinase production in keratinocytes. J Invest Dermatol (2004) 0.83
MicroRNAs, wild-type and mutant p53: more questions than answers. RNA Biol (2012) 0.82
A biochemical approach to identify direct microRNA targets. Methods Mol Biol (2015) 0.77
Micromanaging senescence. Aging (Albany NY) (2010) 0.76